World

Pfizer, BioNTech Partner With South African Firm

Drugmakers Pfizer and BioNTech announced that they will collaborate (News24) with South Africa’s Biovac Institute to deliver more than one hundred million doses per year of their COVID-19 vaccine to African countries beginning in 2022.

Drugmakers Pfizer and BioNTech announced that they will collaborate (News24) with South Africa’s Biovac Institute to deliver more than one hundred million doses per year of their COVID-19 vaccine to African countries beginning in 2022. The active ingredient for the vaccines will be made in Europe, and doses will be finished in Cape Town.

Madagascar: Authorities arrested six people (AFP, Reuters) for allegedly plotting to assassinate President Andry Rajoelina.

Related Articles

Leave a Reply

Back to top button